Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 May 19;15:3551–3562. doi: 10.2147/IJN.S246484

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Mazur et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Bacterial growth pattern in the presence of gentamicin and silver nanoparticles.

Notes: (A) Growth pattern of S.epidermidis K/8605/12 in the presence of gentamicin and SNPs. The dilutions of gentamicin (in range of 0.97 to 250 μg/mL) were made from left to the right side of the plate, dilutions of SNPs (in range of 21.5 to 1400 μg/mL) were made from upper to lower rows of the plate. The FIC index was established on the growth inhibition border. Minimal FIC index (0.12) identified the point where synergistic effect was the most prominent*. For each well, optical density (mean from duplicate measurements) were presented. (B)Photography of the growth of the presented strain of Staphylococcus epidermidis K/8605/12.

Abbreviations: FIC, fractional inhibitory concentration; SNPs, silver nanoparticles